Bioventus Inc (BVS) Inventory Turnover Ratio, from second quarter 2026 to second quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket
 
Bioventus Inc   (NASDAQ: BVS)
 

Bioventus Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Bioventus Inc inventory turnover ratio, the Bioventus Inc 's ability to sell and replace its inventory in the second quarter 2026, sequentially increased to 2.14 in the second quarter 2026, BVS's markets remain strong, its supply chain continue to be in a grate shape.Average inventory processing period, for the Bioventus Inc in Jun 27 2026 quarter, has decreased to 171 days, compare to 181 days, in the Mar 28 2026 quarter.

Within Healthcare sector 187 other companies have achieved higher inventory turnover ratio. While Inventory turnover ratio total ranking has improved so far during the II Quarter 2026, to 1566, from total ranking in the first quarter 2026 at 1776.

BVS Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Bioventus Inc Market Share?

What is Inventory Turnover Ratio?




BVS Inventory Turnover Ratio (Jun 27 2026)
II. Quarter
(Mar 28 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 27 2025)
III. Quarter
(Jun 28 2025)
II. Quarter
Y / Y Inventory Growth -17.27 % -11.55 % -11.07 % 6.93 % 10.11 %
Y / Y Cost of Sales Growth 4.33 % 2.5 % -3.85 % -2.22 % -3.04 %
Inventory Turnover Ratio (TTM) 2.14 2.02 1.95 1.92 1.96
BVS's Total Ranking # 1566 # 1776 # 1634 # 1619 # 1589
Average inventory processing period 171 181 188 191 186
Seq. Inventory Growth -4.06 % 1.16 % -14.58 % -0.2 % 2.57 %
Seq. Cost of Sales Growth 15.96 % -18 % 13.64 % -3.45 % 13.93 %




Inventory Turnover Ratio Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 81
Healthcare Sector # 188
Overall Market # 1566

Inventory Turnover Ratio Statistics
High Average Low
2.98 2.11 0.4
(Apr 02 2022)   (Apr 03 2021)




Financial Statements
Bioventus Inc 's Inventories $ 80 Millions Visit BVS's Balance sheet
Bioventus Inc 's Cost of Revenues TTM $ 183 Millions Visit BVS's Income Statement
What are BVS's Sales? Visit BVS's Sales by Segment

Other Inventory Turnover Ratios
Bioventus Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Medical Equipment & Supplies Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
BVS's Inventory Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for BVS's Competitors
Inventory Turnover Ratio for BVS's Suppliers
Inventory Turnover Ratio for BVS's Customers

You may also want to know
BVS's Sales Growth Rates BVS's Pe Price to earnings ratio BVS's Receivables Turnover Ratio BVS's Stock Quote
BVS's Net Income Growth Rates BVS's Ps Price to Sales ratio BVS's Sales per Employee BVS's Asset Turnover Ratio
BVS's Net Margin BVS's Pb Price to Book ratio BVS's Financial Strength Ratios BVS's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Jun 27 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Jun 27 2026 Inventories at quarter ending Jun 27 2026
Adm Tronics Unlimited Inc   6.05 $ 1.970  Millions$ 0  Millions
Sharps Technology Inc   5.68 $ 2.869  Millions$ 1  Millions
Transmedics Group Inc   5.59 $ 276.120  Millions$ 49  Millions
Cg Oncology Inc   5.47 $ 7.609  Millions$ 1  Millions
Opko Health Inc   5.42 $ 348.206  Millions$ 64  Millions
Charles River Laboratories International inc   5.39 $ 1,761.363  Millions$ 327  Millions
Tactile Systems Technology Inc   5.12 $ 81.349  Millions$ 16  Millions
Integer Holdings Corporation  5.03 $ 1,369.168  Millions$ 272  Millions
Collegium Pharmaceutical Inc   4.99 $ 293.290  Millions$ 59  Millions
Harrow Inc   4.93 $ 73.636  Millions$ 15  Millions
Ufp Technologies Inc   4.93 $ 452.046  Millions$ 92  Millions
Veracyte Inc   4.84 $ 102.741  Millions$ 21  Millions
West Pharmaceutical Services Inc   4.72 $ 2,103.100  Millions$ 445  Millions
Henry Schein Inc   4.68 $ 9,342.000  Millions$ 1,997  Millions
Guardant Health Inc   4.53 $ 413.947  Millions$ 91  Millions
Idexx Laboratories Inc  4.44 $ 1,714.440  Millions$ 386  Millions
Cryoport inc   4.40 $ 98.679  Millions$ 22  Millions
Envista Holdings Corporation  4.37 $ 1,278.500  Millions$ 293  Millions
Adc Therapeutics Sa  4.17 $ 5.806  Millions$ 1  Millions
Scilex Holding Company  4.08 $ 14.867  Millions$ 4  Millions
Medinotec Inc   4.08 $ 4.736  Millions$ 1  Millions
Alpha Teknova Inc   4.08 $ 28.288  Millions$ 7  Millions
3m Company  4.07 $ 15,258.000  Millions$ 3,754  Millions
Electromed Inc   4.02 $ 14.133  Millions$ 4  Millions
Novocure Limited  4.02 $ 166.921  Millions$ 41  Millions
Elite Pharmaceuticals Inc   3.95 $ 78.824  Millions$ 20  Millions
Lftd Partners Inc   3.89 $ 29.233  Millions$ 8  Millions
Pmgc Holdings Inc   3.87 $ 1.364  Millions$ 0  Millions
Sonoma Pharmaceuticals Inc   3.83 $ 13.392  Millions$ 3  Millions
Intelligent Bio Solutions Inc   3.80 $ 2.165  Millions$ 1  Millions

Date modified: 2026-09-09T22:40:19+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.